ENGINEERED IgG MOLECULES AND METHODS OF USE THEREOF
US-2026092123-A1 · Apr 2, 2026 · US
This page is not indexed by search engines while we improve data quality.
Davis Samuel patents
Davis Samuel is listed as an inventor on 90 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Davis Samuel |
| Total patents | 90 |
| First publication | Feb 26, 2015 |
| Latest publication | Apr 2, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Heavy Chain Constant Regions with Reduced Binding to Fc Gamma Receptors
US-2026085116-A1 · Mar 26, 2026 · US
Antibodies Comprising Chimeric Constant Domains
US-2026085117-A1 · Mar 26, 2026 · US
Vegf antagonists and methods of use thereof
US-2026055171-A1 · Feb 26, 2026 · US
IL2-based therapeutics and methods of use thereof
US-12528851-B2 · Jan 20, 2026 · US
IL12 receptor agonists and methods of use thereof
US-12522638-B2 · Jan 13, 2026 · US
Antibodies comprising chimeric constant domains
US-12509514-B2 · Dec 30, 2025 · US
Heavy chain constant regions with reduced binding to Fc gamma receptors
US-12509516-B2 · Dec 30, 2025 · US
Antigen binding molecule formats
US-2025333492-A1 · Oct 30, 2025 · US
Masked Multispecific Antigen-Binding Molecules with Cleavable Linkers
US-2025297006-A1 · Sep 25, 2025 · US
Recent patents
Latest publications not already listed above.
Il-2 variants with reduced binding to il-2 receptor alpha and uses thereof
US-2025296969-A1 · Sep 25, 2025 · US
Novel antigen binding molecule formats
US-2025289883-A1 · Sep 18, 2025 · US
Antigen binding molecule formats
US-12391753-B2 · Aug 19, 2025 · US
Antigen binding molecule formats
US-12331109-B2 · Jun 17, 2025 · US
Novel antigen binding molecule formats
US-2025109194-A1 · Apr 3, 2025 · US
Chimeric heavy chain constant domains with reduced binding to fc gamma receptors and uses thereof
US-2025109207-A1 · Apr 3, 2025 · US
Il12 receptor agonists and methods of use thereof
US-2025066441-A1 · Feb 27, 2025 · US
Antigen binding molecule formats
US-12215148-B2 · Feb 4, 2025 · US
Glucagon-like peptide 1 receptor agonists and uses thereof
US-2025000949-A1 · Jan 2, 2025 · US
Antigen binding molecule formats
US-12180272-B2 · Dec 31, 2024 · US
Il-2 variants with reduced binding to IL-2 receptor alpha and uses thereof
US-12168681-B2 · Dec 17, 2024 · US
Readily isolated bispecific antibodies with native immunoglobulin format
US-12157758-B2 · Dec 3, 2024 · US
Glucagon-like peptide 1 receptor agonists and uses thereof
US-12090193-B2 · Sep 17, 2024 · US
Novel antigen binding molecule formats
US-2024294627-A1 · Sep 5, 2024 · US
Il12 receptor agonists and methods of use thereof
US-2024270836-A1 · Aug 15, 2024 · US
Common light chain mouse
US-2024156070-A1 · May 16, 2024 · US
Antigen binding molecule formats
US-11965020-B2 · Apr 23, 2024 · US
Il-2 variants with reduced binding to il-2 receptor alpha and uses thereof
US-2024067690-A1 · Feb 29, 2024 · US
Glucagon-like peptide 1 receptor agonists and uses thereof
US-2024024428-A1 · Jan 25, 2024 · US
IL-2 variants with reduced binding to IL-2 receptor alpha and uses thereof
US-11834485-B2 · Dec 5, 2023 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Regeneron Pharma | 90 |
| Regeneran Pharmaceuticals Inc | 2 |
| Regeneren Pharmaceuticals Inc | 2 |
| Davis Samuel | 1 |
| Smith Eric | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/31 | 55 |
| C07K16/2809 | 49 |
| C07K2317/52 | 47 |
| C07K2317/53 | 41 |
| C07K2317/92 | 41 |